Sam Slutsky

Stock Analyst at LifeSci Capital

(2.69)
# 2,149
Out of 5,044 analysts
3
Total ratings
66.67%
Success rate
20.37%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sam Slutsky

Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $73.50
Upside: +22.45%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45$101
Current: $94.25
Upside: +7.17%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $1.51
Upside: -